DJ Vor Biopharma Larger IPO Prices at Top of Expectations
By Colin Kellaher
Vor Biopharma Inc. on Friday said its upsized initial public offering of 9.83 million shares was priced at $18 each, at the high end of the expected range.
The Cambridge, Mass., cell-therapy company previously planned to sell 8.82 million shares at between $16 and $18 apiece in the IPO.
Vor said it expects gross proceeds of about $176.9 million, adding that it granted the underwriters a 30-day option to buy up to an additional 1.47 million shares.
Vor shares are due to begin trading Friday under the symbol VOR.
Write to Colin Kellaher at firstname.lastname@example.org
(END) Dow Jones Newswires
February 05, 2021 07:00 ET (12:00 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.